Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 3Y Ago
-2.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -27.13% |
| 2024 | 15.39% |
| 2023 | 7.77% |
| 2022 | 13.01% |
| 2021 | 52.66% |
| 2020 | -6.52% |
| 2019 | 13.90% |
| 2018 | 58.32% |
| 2017 | 10.32% |
| 2016 | 40.51% |